Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple negative breast cancer treated by induction chemotherapy with or without oral low dose cyclophosphamide-methotrexate maintenance chemotherapy (CMM)
Abstract
Data di Pubblicazione:
2016
Citazione:
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple negative breast cancer treated by induction chemotherapy with or without oral low dose cyclophosphamide-methotrexate maintenance chemotherapy (CMM) / G. Pruneri, K.P.G.. - In: CANCER RESEARCH. - ISSN 0008-5472. - 76:suppl. 4(2016), pp. P2-08-02.1-P2-08-02.1. (38. Annual CTRC-AACR San Antonio Breast Cancer Symposium San Antonio 2015) [10.1158/1538-7445.SABCS15-P2-08-02].
Tipologia IRIS:
01 - Articolo su periodico
Elenco autori:
G. Pruneri, K.P. Gray, A. Vingiani, G. Viale, G. Curigliano, C. Criscitiello, I. Láng, T. Ruhstaller, L. Gianni, A. Goldhirsch, R. Kammler, K.N. Price, G. Cancello, E. Munzone, R.D. Gelber, M.M. Regan, M. Colleoni
Link alla scheda completa: